SaNOtize Research and Development
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $24M
Investors
- 4
About SaNOtize Research and Development
Founded in 2017 and based in Vancouver, British Columbia, Canada, SaNOtize Research and Development Corp.a SaNOtize operates as a pharmaceutical company that leverages the antimicrobial properties of nitric oxide (NO), a naturally occurring molecule known to have antibacterial, antifungal, and antiviral properties. The company was founded by CEO, Dr. Gilly Regev and Chief Scientific Officer Dr. Chris Miller. In August 2022, SaNOtize Research and Development Corp. The company developed a Nitric Oxide Releasing Solution platform technology to help treat microbial infections such as Covid-19, influenza, and other viruses. The company's therapeutics pipeline includes Nitric Oxide Nasal Spray (NONS) is sold as a medical device in Thailand, Singapore, Hong Kong, Nepal, South Africa, and Germany under the brand VirX, in Israel, Indonesia, and Bahrain under the brand enovid. In India, NONS is available with a prescription under the name FabiSpray. Other therapeutics in the pipeline include treatment for Chronic sinusitis, diabetic foot ulcer, and nail fungus (onychomycosis.
Who invested in SaNOtize Research and Development
4 investors across 2 rounds
See all investors in SaNOtize Research and Development
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SaNOtize Research and Development
Who invested in SaNOtize Research and Development?
SaNOtize Research and Development has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SaNOtize Research and Development raised?
SaNOtize Research and Development has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SaNOtize Research and Development last raise money?
SaNOtize Research and Development's most recent round on record is a Series B, in Aug 2022.
What does SaNOtize Research and Development do?
Founded in 2017 and based in Vancouver, British Columbia, Canada, SaNOtize Research and Development Corp.
Where is SaNOtize Research and Development headquartered?
SaNOtize Research and Development is headquartered in Vancouver, Canada.
Which VCs invest in companies like SaNOtize Research and Development?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SaNOtize Research and Development's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like SaNOtize Research and Development? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.